impact factor, citescore
logo
 

Letters to the Editor

 

Abortion of the UVEXATE study: are we unable to evaluate cheap and well-tolerated treatments?


1, 2, 3

 

  1. Service de Médecine Interne, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris (AP-HP); Université Paris 13, Sorbonne Paris Cité, Bobigny, France.
  2. Unité de Recherche Clinique, Hôpital Fernand Widal, AP-HP; Université Paris 7, France.
  3. Service de Médecine Interne, Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris (AP-HP); Université Paris 13, Sorbonne Paris Cité, Bobigny, France. sebastien.abad@avc.aphp.fr

CER9762
2017 Vol.35, N°1
PI 0175
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 27749231 [PubMed]

Received: 15/07/2016
Accepted : 20/07/2016
In Press: 07/09/2016
Published: 26/01/2017

Rheumatology Article